Trevena, Inc. (TRVN)
NASDAQ: TRVN · IEX Real-Time Price · USD
0.225
-0.003 (-1.18%)
At close: Jul 26, 2024, 3:54 PM
0.234
+0.009 (3.99%)
After-hours: Jul 26, 2024, 7:37 PM EDT
Trevena Market Cap
Trevena has a market cap or net worth of $4.15 million as of July 26, 2024. Its market cap has decreased by -60.13% in one year.
Market Cap
4.15M
Enterprise Value
-14.75M
1-Year Change
-60.13%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from $145.40M to $4.15M, a decrease of -97.15%. That is a compound annual growth rate of -28.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 4.20M | -61.82% |
| Dec 29, 2023 | 11.00M | 11.11% |
| Dec 30, 2022 | 9.90M | -89.67% |
| Dec 31, 2021 | 95.80M | -71.49% |
| Dec 31, 2020 | 336.00M | 331.32% |
| Dec 31, 2019 | 77.90M | 120.06% |
| Dec 31, 2018 | 35.40M | -64.49% |
| Dec 29, 2017 | 99.70M | -67.60% |
| Dec 30, 2016 | 307.70M | -42.28% |
| Dec 31, 2015 | 533.10M | 237.83% |
| Dec 31, 2014 | 157.80M | 8.53% |
| Jan 31, 2014 | 145.40M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonnet BioTherapeutics Holdings | 4.45M |
| MyMD Pharmaceuticals | 4.31M |
| Allarity Therapeutics | 4.26M |
| Evoke Pharma | 4.23M |
| Genprex | 4.20M |
| China Pharma Holdings | 4.10M |
| Fresh2 Group | 4.08M |
| CERo Therapeutics Holdings | 4.07M |